The cell cycle arrest and the anti-invasive effects of nitrogen-containing bisphosphonates are not mediated by DBF4 in breast cancer cells

Biochimie

Volumn 99, Issue 1, 2014, Pages 71-76

  Mansouri, Mahdieh ^a   Mirzaei, Seyed Abbas ^a,b   Lage, Hermann ^b   Mousavi, Seyyedeh Soghra ^a   Elahian, Fatemeh ^a,b  

^a ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Bisphosphonates; Cell cycle; DBF4; Invasion assay; Risedronate; Zoledronate

Indexed keywords

BISPHOSPHONATES; CELL CYCLE; DBF4; INVASION ASSAY; RISEDRONATE; ZOLEDRONATE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DIPHOSPHONATES; DRUG SCREENING ASSAYS, ANTITUMOR; ETIDRONIC ACID; FEMALE; HUMANS; IMIDAZOLES; INHIBITORY CONCENTRATION 50; NEOPLASM INVASIVENESS;

EID: 84894096117     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.11.010     Document Type: Article

References (23)

1. N.B. Watts, and D.L. Diab Long-term use of bisphosphonates in osteoporosis Clin. Endocrinol. Metab 4 2010 1555 1565
2. A. Tripathi, S. Pandey, S.V. Singh, N.K. Sharma, and R. Singh Bisphosphonate therapy for skeletal malignancies and metastases: impact on jaw bones and prosthodontic concerns Prosthodontics 2010 601 603
3. M.R. Smith Antitumor activity of bisphosphonates Clin. Cancer Res. 9 2003 5433 5434
4. D. Santini, S. Galluzzo, B. Vincenzi, G. Schiavon, E. Fratto, F. Pantano, and G. Tonini New developments of aminobisphosphonates: the double face of Janus Ann. Oncol. 18 2007 64 67
5. S.G. Senaratne, G. Pirianov, J.L. Mansi, T.R. Arnett, and K.W. Colston Bisphosphonates induce apoptosis in human breast cancer cell lines Br. J. Cancer 82 2000 1459 1468
6. P.G. Fournier, V. Stresing, F.H. Ebetino, and P. Clezardin How do bisphosphonates inhibit bone metastasis in vivo? Neoplasia 12 2010 571 578
7. F.P. Coxon, K. Thompson, and M.J. Rogers Recent advances in understanding the mechanism of action of bisphosphonates Curr. Opin. Pharmacol. 6 2006 307 312
8. N. Bivi, M. Romanello, R. Harrison, I. Clarke, D.C. Hoyle, L. Moro, F. Ortolani, A. Bonetti, F. Quadrifoglio, G. Tell, and D. Delneri Identification of secondary targets of N-containing bisphosphonates in mammalian cells via parallel competition analysis of the barcoded yeast deletion collection Genome Biol. 10 2009 R93
9. M. Balestri, F. Taddei, M. Viceconti, and M. Manfrini Tibial bone adaptation after fibula osteotomy: an in-vivo analysis Forum in Bone and Mineral Research 6th Meeting Napoli 85 2009 451 462
10. B.Q. Guo, J. Romero, B.J. Kim, and H. Lee High levels of Cdc7 and Dbf4 proteins can arrest cell-cycle progression Eur. J. Cell Biol. 84 2005 927 938
11. Y. Chen, B. Lu, Q. Yang, C. Fearns, J.R. Yates, and J.D. Lee Combined integrin phosphoproteomic analyses and siRNAbased functional screening identified key regulators for cancer cell adhesion and migration Cancer Res. 69 2009 3713 3720
12. F. Elahian, F. Kalalinia, and J. Behravan Dexamethasone downregulates BCRP mRNA and protein expression in breast cancer cell lines Oncol. Res. 18 2009 9 15
13. F. Elahian, F. Kalalinia, and J. Behravan Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell lines Drug Chem. Toxicol 33 2010 113 119
14. F. Elahian, B. Moghimi, F. Dinmohammadi, M. Ghamghami, M. Hamidi, and S.A. Mirzaei The anticancer agent prodigiosin is not a multidrug resistance protein substrate DNA Cell. Biol. 32 2013 90 97
15. S.A. Mirzaei, M.T. Yazdi, and Z. Sepehrizadeh Secretory expression and purification of a soluble NADH cytochrome b5 reductase enzyme from Mucor racemosus in Pichia pastoris based on codon usage adaptation Biotechnol. Lett. 32 2010 1705 1711
16. H. Lage, C. Perlitz, R. Abele, R. Tampé, M. Dietel, D. Schadendorf, and P. Sinha Enhanced expression of human ABC-transporter tap is associated with cellular resistance to mitoxantrone FEBS Lett. 503 2001 179 184
17. K. Velpula, V. Dasari, A. Tsung, C. Gondi, J. Klopfenstein, S. Mohanam, and J. Rao Regulation of glioblastoma progression by cord blood stem cells is mediated by downregulation of cyclin D1 PLoS ONE 6 2011 1 13
18. B. Grismayer, S. Sölch, B. Seubert, T. Kirchner, S. Schäfer, G. Baretton, M. Schmitt, T. Luther, A. Krüger, M. Kotzsch, and V. Magdolen Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells Mol. Cancer 11 2012 1 14
19. H. Fleisch, R. Russell, S. Bisaz, P. Casey, and R. Mühlbauer The influence of pyrophosphate analogues (diphosphonates) on the precipitation and dissolution of calcium phosphate in vitro and in vivo Calcif. Tissue Res. 2 1968 10-10a
20. R. Verdijk, H.R. Franke, F. Wolbers, and I. Vermes Differential effects of bisphosphonates on breast cancer cell lines Cancer Lett. 246 2007 308 312
21. Y.J. Sheu, and B. Stillman Cdc7-Dbf4 phosphorylates MCM proteins via a docking site-mediated mechanism to promote S phase progression Mol. Cell 24 2006 101 113
22. D. Bonte, C. Lindvall, H.Y. Liu, K. Dykema, K. Furge, and M. Weinreich Cdc7-Dbf4 kinase overexpression in multiple cancers and tumor cell lines is correlated with p53 inactivation Neoplasia 10 2008 920 931
23. F. Elahian, Z. Sepehrizadeh, B. Moghimi, and S.A. Mirzaei Human cytochrome b5 reductase: structure, function, and potential applications Crit. Rev. Biotechnol 2012 10.3109/07388551.2012.732031 (Epub ahead of print)